Moreover, miRNA-449a inhibits the invasion of NSCLC cells by inhibiting MAP2K1 [46], while miR-183-5p inhibits p53, thereby promoting the metastasis of NSCLC [47]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.